MD MEd MBBS (Hons) BSc (Hons) FRCS (Eng)
Senior Clinical Research Fellow and Consultant Surgeon
- Senior Clinical Research Fellow, Cancer Epidemiology Unit
- Consultant Oncoplastic Breast Surgeon, Oxford University Hospitals NHS Foundation Trust
- Senior Research Fellow, Green Templeton College
Toral Gathani is a Senior Clinical Research Fellow in the Cancer Epidemiology Unit of the Nuffield Department of Population Health, University of Oxford and Consultant Oncoplastic Breast Surgeon at Oxford University Hospitals NHS Foundation Trust. She was appointed Senior Research Fellow at Green Templeton College in 2019.
She studied Medicine at the University of St Andrews and Guy’s and St Thomas’ Medical School graduating in 1999 with Honours. She undertook her surgical training in London and at the Nottingham Breast Institute. Toral was a research fellow in the Cancer Epidemiology Unit in 2003-2006 where she undertook the research for her MD thesis.
She is the Principal Investigator for a Cancer Research UK funded project on the Associations of Ethnicity and Breast Cancer. The Royal College of Surgeons of England awarded her a prestigious Hunterian Lecture, and courtesy title of Hunterian Professor 2022, for her work in this area. She is the Co-Chief Investigator of the AgeX Trial assessing the benefits and risks of extending the age range for routine screening invitations.
She has spent time working in India in a research and clinical capacity, and is a past recipient of a British Medical Association Humanitarian Award for public health related work in Assam, India.
Nationally, she is a member of the Clinical Advisory Panel for Cancer Research UK, the Academic and Research Committee for the Association of Breast Surgery, and the Audit Advisory Committee for the National Audit of Primary Breast Cancer.
Her main interests are in the intersection of ethnicity and breast cancer in women in the UK, the role of health systems in early cancer diagnosis and of breast cancer as a global health challenge.
Age and sex can predict cancer risk in people referred with breast symptoms.
Gathani T. et al, (2023), BMJ, 381
Cutress RI. and Gathani T., (2023), Ann R Coll Surg Engl, 105, 291 - 292
The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England.
Gathani T. et al, (2022), Br J Cancer, 1 - 3
The burden of risk factors for non-communicable disease in rural Bihar, India: a comparative study with national health surveys.
Ross S. et al, (2022), BMC Public Health, 22
Impact of the COVID-19 pandemic on breast cancer referrals and diagnoses in 2020 and 2021: a population-based study in England.
Gathani T. et al, (2022), Br J Surg, 109, e29 - e30